Hollsteen
← Intuit

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $213M · 10-Q 0000896878-15-000140 filed Nov 20, 2015Research and development · Q2 FY2016: $205M · 10-Q 0000896878-16-000197 filed Feb 25, 2016Research and development · Q3 FY2016: $228M · 10-Q 0000896878-16-000225 filed May 24, 2016Research and development · Q4 FY2016: $235M · derived · 10-K 0000896878-17-000130 filed Sep 1, 2017Research and development · Q1 FY2017: $246M · 10-Q 0000896878-16-000316 filed Nov 18, 2016Research and development · Q2 FY2017: $243M · 10-Q 0000896878-17-000030 filed Feb 23, 2017Research and development · Q3 FY2017: $246M · 10-Q 0000896878-17-000048 filed May 23, 2017Research and development · Q4 FY2017: $263M · derived · 10-K 0000896878-18-000171 filed Aug 31, 2018Research and development · Q1 FY2018: $293M · 10-Q 0000896878-17-000170 filed Nov 20, 2017Research and development · Q2 FY2018: $286M · 10-Q 0000896878-18-000036 filed Feb 22, 2018Research and development · Q3 FY2018: $296M · 10-Q 0000896878-18-000075 filed May 22, 2018Research and development · Q4 FY2018: $311M · derived · 10-K 0000896878-19-000132 filed Aug 30, 2019Research and development · Q1 FY2019: $294M · 10-Q 0000896878-18-000212 filed Nov 20, 2018Research and development · Q2 FY2019: $295M · 10-Q 0000896878-19-000042 filed Feb 22, 2019Research and development · Q3 FY2019: $311M · 10-Q 0000896878-19-000077 filed May 23, 2019Research and development · Q4 FY2019: $333M · derived · 10-K 0000896878-20-000148 filed Aug 31, 2020Research and development · Q1 FY2020: $334M · 10-Q 0000896878-19-000174 filed Nov 21, 2019Research and development · Q2 FY2020: $333M · 10-Q 0000896878-20-000027 filed Feb 24, 2020Research and development · Q3 FY2020: $332M · 10-Q 0000896878-20-000065 filed May 21, 2020Research and development · Q4 FY2020: $393M · derived · 10-K 0000896878-21-000233 filed Sep 8, 2021Research and development · Q1 FY2021: $325M · 10-Q 0000896878-20-000223 filed Nov 19, 2020Research and development · Q2 FY2021: $368M · 10-Q 0000896878-21-000059 filed Feb 23, 2021Research and development · Q3 FY2021: $464M · 10-Q 0000896878-21-000115 filed May 25, 2021Research and development · Q4 FY2021: $521M · derived · 10-K 0000896878-22-000028 filed Sep 2, 2022Research and development · Q1 FY2022: $530M · 10-Q 0000896878-21-000260 filed Nov 18, 2021Research and development · Q2 FY2022: $590M · 10-Q 0000896878-22-000010 filed Mar 2, 2022Research and development · Q3 FY2022: $600M · 10-Q 0000896878-22-000021 filed May 24, 2022Research and development · Q4 FY2022: $627M · derived · 10-K 0000896878-23-000034 filed Sep 1, 2023Research and development · Q1 FY2023: $625M · 10-Q 0000896878-22-000036 filed Nov 29, 2022Research and development · Q2 FY2023: $630M · 10-Q 0000896878-23-000010 filed Feb 23, 2023Research and development · Q3 FY2023: $604M · 10-Q 0000896878-23-000020 filed May 23, 2023Research and development · Q4 FY2023: $680M · derived · 10-K 0000896878-24-000039 filed Sep 4, 2024Research and development · Q1 FY2024: $680M · 10-Q 0000896878-23-000041 filed Nov 28, 2023Research and development · Q2 FY2024: $678M · 10-Q 0000896878-24-000011 filed Feb 22, 2024Research and development · Q3 FY2024: $671M · 10-Q 0000896878-24-000026 filed May 23, 2024Research and development · Q4 FY2024: $725M · derived · 10-K 0000896878-25-000035 filed Sep 3, 2025Research and development · Q1 FY2025: $704M · 10-Q 0000896878-24-000053 filed Nov 21, 2024Research and development · Q2 FY2025: $716M · 10-Q 0000896878-25-000015 filed Feb 25, 2025Research and development · Q3 FY2025: $707M · 10-Q 0000896878-25-000022 filed May 22, 2025Research and development · Q4 FY2025: $801M · derived · 10-K 0000896878-26-000037 filed Sep 9, 2026Research and development · Q1 FY2026: $843M · 10-Q 0000896878-25-000048 filed Nov 20, 2025Research and development · Q2 FY2026: $836M · 10-Q 0000896878-26-000014 filed Feb 26, 2026Research and development · Q3 FY2026: $840M · 10-Q 0000896878-26-000025 filed May 20, 2026Research and development · Q4 FY2026: $857M · derived · 10-K 0000896878-26-000037 filed Sep 9, 2026464857a213Q1 FY2016Q4 FY2026Q3 FY2021
$MResearch and development · Q3 FY2020: $332M · 10-Q 0000896878-20-000065 filed May 21, 2020Research and development · Q4 FY2020: $393M · derived · 10-K 0000896878-21-000233 filed Sep 8, 2021Research and development · Q1 FY2021: $325M · 10-Q 0000896878-20-000223 filed Nov 19, 2020Research and development · Q2 FY2021: $368M · 10-Q 0000896878-21-000059 filed Feb 23, 2021Research and development · Q3 FY2021: $464M · 10-Q 0000896878-21-000115 filed May 25, 2021Research and development · Q4 FY2021: $521M · derived · 10-K 0000896878-22-000028 filed Sep 2, 2022Research and development · Q1 FY2022: $530M · 10-Q 0000896878-21-000260 filed Nov 18, 2021Research and development · Q2 FY2022: $590M · 10-Q 0000896878-22-000010 filed Mar 2, 2022464590332Q3 FY2020Q2 FY2022Q3 FY2021
Q3 FY2021
464$M
All values (44)
PeriodValue ($M)Status
Q4 FY2026857derived
Q3 FY2026840reported
Q2 FY2026836reported
Q1 FY2026843reported
Q4 FY2025801derived
Q3 FY2025707reported
Q2 FY2025716reported
Q1 FY2025704reported
Q4 FY2024725derived
Q3 FY2024671reported
Q2 FY2024678reported
Q1 FY2024680reported
Q4 FY2023680derived
Q3 FY2023604reported
Q2 FY2023630reported
Q1 FY2023625reported
Q4 FY2022627derived
Q3 FY2022600reported
Q2 FY2022590reported
Q1 FY2022530reported
Q4 FY2021521derived
Q3 FY2021464reported
Q2 FY2021368reported
Q1 FY2021325reported
Q4 FY2020393derived
Q3 FY2020332reported
Q2 FY2020333reported
Q1 FY2020334reported
Q4 FY2019333derived
Q3 FY2019311reported
Q2 FY2019295reported
Q1 FY2019294reported
Q4 FY2018311derived
Q3 FY2018296reported
Q2 FY2018286reported
Q1 FY2018293reported
Q4 FY2017263derived
Q3 FY2017246reported
Q2 FY2017243reported
Q1 FY2017246reported
Q4 FY2016235derived
Q3 FY2016228reported
Q2 FY2016205reported
Q1 FY2016213reported

CSV with all sources · Technical ID: rnd

More metrics for Intuit

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$464M
Period
Q3 FY2021, ended Apr 30, 2021 · quarterly value (3 months, not cumulative)
Source
10-Q, filed May 25, 2021 · 0000896878-21-000115
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$464MMay 25, 202110-Q 0000896878-21-000115reported · confidence 1. · current